DCA vs PC/DCA: Choosing the Right Lipolytic Agent for Your Patient
Two agents dominate injectable lipolytic practice: deoxycholic acid (DCA) as a single agent, and phosphatidylcholine combined with deoxycholic acid (PC/DCA) as a combination formulation. Both destroy subcutaneous fat cells, both produce the inflammatory clearance response that delivers the result, and both are available as CE-marked Korean formulations at Celmade. But they are not identical — and practitioners who understand the specific differences between them are better positioned to choose the right product for each clinical situation.
Lipolytic Injectables: The Complete Practitioner's Guide
Injectable lipolytics — agents that chemically destroy subcutaneous fat cells — represent one of the most technically specific and outcome-dependent treatments in non-surgical aesthetic medicine. When patient selection is correct, the treatment zone is appropriate, the product and protocol are sound, and the patient's expectations are accurately set, injectable lipolytics produce permanent, visible, and highly valued results. When any of these elements is wrong, the risk of adverse outcomes — prolonged swelling, irregular contour, nerve injury — increases substantially.
